Who We Are

The CIHR Canadian HIV Trials Network (CTN) is an innovative partnership of clinical investigators, physicians, nurses, people living with HIV, pharmaceutical manufacturers and others that facilitate clinical trials of the highest scientific and ethical standards for HIV and related conditions.

What We Do

Established in 1990 by the Canadian government as a cornerstone in its Federal Initiative to Address HIV/AIDS in Canada, the CTN is an innovative partnership committed to developing treatments, vaccines and a cure for HIV and AIDS through the conduct of scientifically sound and ethical clinical trials.

Media Contact

For all media enquiries contact:
Michaela Davies
Director, Communications
Phone: 604 806 8306

Toll-Free: 1 800 661 4664
E-mail: media[at]hivnet.ubc.ca


The Early History of the CTN’s Community Advisory Committee (CAC)

Shari Margolese: HIV Research and Community Participation

HIV Vaccine Research in Canada: Interview with the Director of the Alliance Coordinating Office

The promise of an HIV vaccine: Dr. Chil-Yong Kang

2013 CIHR Canadian HIV Trials Network HIV-HCV Co-infection Guidelines

Course: Pushing the Boundaries of HIV Care

Dr. Mark Wainberg: HIV research and the hope for a cure

The CTN and the struggle against HIV in Saskatchewan: with David Cox

Latest News

Let’s Talk About Stigma: HIV in 2020

| Uncategorized | No Comments

We talked to three community members to get their unique perspectives on the pervasive impact of HIV-related stigma and what we can do to combat it

Could Cannabis Help Prevent HIV-Related Illnesses?

| Uncategorized | No Comments

CTN Investigators Drs. Cecilia Costiniuk and Ali Jenabian publish a thorough editorial review of cannabis research in HIV and inflammation

CHANGE HIV: A Healthy Aging Study

| Uncategorized | No Comments

There is so much we do not know about HIV and aging, but the CHANGE HIV study (CTN 314) is setting out to answer some of these unknowns

CTN 281: Canadian Children Falling Short of UNAIDS target

| Uncategorized | No Comments

A new publication from the EPIC4 Study (CTN 281) found that 73% of Canadian children living with HIV achieved a sustained undetectable viral load